+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ciclosporin"

From
Uveitis Drugs - Global Strategic Business Report - Product Thumbnail Image

Uveitis Drugs - Global Strategic Business Report

  • Report
  • May 2026
  • 413 Pages
  • Global
From
Ocular Immunosuppressants Market - Global Forecast 2026-2032 - Product Thumbnail Image

Ocular Immunosuppressants Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Psoriasis Market Report 2026 - Product Thumbnail Image

Psoriasis Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Systemic Lupus Erythematosus Treatment Market Report 2026 - Product Thumbnail Image

Systemic Lupus Erythematosus Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Chronic Spontaneous Urticaria - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Spontaneous Urticaria - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Plaque Psoriasis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Plaque Psoriasis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Plaque Psoriasis Pipeline Analysis Report 2025 - Product Thumbnail Image

Plaque Psoriasis Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Moderate Psoriasis Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Moderate Psoriasis Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Severe Psoriasis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Severe Psoriasis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Kawasaki Disease Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Kawasaki Disease Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
From
From
From
Myasthenia Gravis: Opportunity Assessment and Forecast - Product Thumbnail Image

Myasthenia Gravis: Opportunity Assessment and Forecast

  • Report
  • June 2025
  • 85 Pages
  • Global
From
Loading Indicator

Ciclosporin is an immunosuppressant drug used to treat a variety of immune disorders, including rheumatoid arthritis, psoriasis, and inflammatory bowel disease. It works by suppressing the body's immune system, which helps to reduce inflammation and prevent organ rejection in transplant patients. It is also used to treat certain types of eye inflammation. Ciclosporin is available in both oral and topical formulations. Ciclosporin is a widely used drug in the treatment of immune disorders, and is often prescribed in combination with other drugs. It is generally well tolerated, with few side effects. However, it can cause serious side effects, such as high blood pressure, kidney damage, and increased risk of infection. The ciclosporin market is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Novartis, Pfizer, Merck, and Sanofi. Other companies include Mylan, Teva, and Sandoz. Show Less Read more